Pseudohypoparathyroidism and GNAS epigenetic defects: Clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients

Giovanna Mantovani, Luisa De Sanctis, Anna Maria Barbieri, Francesca M. Elli, Valentina Bollati, Valentina Vaira, Pamela Labarile, Sara Bondioni, Erika Peverelli, Andrea G. Lania, Paolo Beck-Peccoz, Anna Spada

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Context: The two main subtypes of pseudohypoparathyroidism (PHP), PHP-Ia and -Ib, are caused by mutations in GNAS exons 1-13 and methylation defects in the imprinted GNAS cluster, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO, and hormone resistance appears to be limited to PTH and TSH. Recently, methylation defects have been detected in few patients with PHP and mild AHO, indicating a molecular overlap between the two forms. Objectives: The aim of the study was to screen patients with clinically diagnosed PHP-Ia for methylation defects and to investigate the presence of correlations between the molecular findings and AHO severity. Patients and Methods: We investigated differential methylation of GNAS regions and STX16 microdeletions in genomic DNA from 40 patients with sporadic AHO and multihormone resistance, with no mutations in Gsα-coding GNAS exons. Results: Molecular analysis showed GNAS cluster imprinting defects in 24 of the 40 patients analyzed. No STX 16 deletion was detected. The presence of imprinting defects was not associated with the severity of AHO or with specific AHO signs. Conclusions: We report the largest series of the literature of patients with clinical AHO and multi-hormone resistance and no mutation in the Gsα gene. Our findings of frequent GNAS imprinting defects further confirm the existence of an overlap between molecular and clinical features of PHP-Ia and PHP-Ib and highlight the necessity of a new clinical classification of the disease that takes into account the recent knowledge on the molecular basis underlying these defects.

Original languageEnglish
Pages (from-to)651-658
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Pseudohypoparathyroidism
Epigenomics
Methylation
Defects
Hormones
Exons
Mutation
Albright's hereditary osteodystrophy
Genes
DNA

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Pseudohypoparathyroidism and GNAS epigenetic defects : Clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. / Mantovani, Giovanna; De Sanctis, Luisa; Barbieri, Anna Maria; Elli, Francesca M.; Bollati, Valentina; Vaira, Valentina; Labarile, Pamela; Bondioni, Sara; Peverelli, Erika; Lania, Andrea G.; Beck-Peccoz, Paolo; Spada, Anna.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 2, 02.2010, p. 651-658.

Research output: Contribution to journalArticle

Mantovani, Giovanna ; De Sanctis, Luisa ; Barbieri, Anna Maria ; Elli, Francesca M. ; Bollati, Valentina ; Vaira, Valentina ; Labarile, Pamela ; Bondioni, Sara ; Peverelli, Erika ; Lania, Andrea G. ; Beck-Peccoz, Paolo ; Spada, Anna. / Pseudohypoparathyroidism and GNAS epigenetic defects : Clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 2. pp. 651-658.
@article{1da5bbe43e7d4bfdb4c3dd521a224417,
title = "Pseudohypoparathyroidism and GNAS epigenetic defects: Clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients",
abstract = "Context: The two main subtypes of pseudohypoparathyroidism (PHP), PHP-Ia and -Ib, are caused by mutations in GNAS exons 1-13 and methylation defects in the imprinted GNAS cluster, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO, and hormone resistance appears to be limited to PTH and TSH. Recently, methylation defects have been detected in few patients with PHP and mild AHO, indicating a molecular overlap between the two forms. Objectives: The aim of the study was to screen patients with clinically diagnosed PHP-Ia for methylation defects and to investigate the presence of correlations between the molecular findings and AHO severity. Patients and Methods: We investigated differential methylation of GNAS regions and STX16 microdeletions in genomic DNA from 40 patients with sporadic AHO and multihormone resistance, with no mutations in Gsα-coding GNAS exons. Results: Molecular analysis showed GNAS cluster imprinting defects in 24 of the 40 patients analyzed. No STX 16 deletion was detected. The presence of imprinting defects was not associated with the severity of AHO or with specific AHO signs. Conclusions: We report the largest series of the literature of patients with clinical AHO and multi-hormone resistance and no mutation in the Gsα gene. Our findings of frequent GNAS imprinting defects further confirm the existence of an overlap between molecular and clinical features of PHP-Ia and PHP-Ib and highlight the necessity of a new clinical classification of the disease that takes into account the recent knowledge on the molecular basis underlying these defects.",
author = "Giovanna Mantovani and {De Sanctis}, Luisa and Barbieri, {Anna Maria} and Elli, {Francesca M.} and Valentina Bollati and Valentina Vaira and Pamela Labarile and Sara Bondioni and Erika Peverelli and Lania, {Andrea G.} and Paolo Beck-Peccoz and Anna Spada",
year = "2010",
month = "2",
doi = "10.1210/jc.2009-0176",
language = "English",
volume = "95",
pages = "651--658",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Pseudohypoparathyroidism and GNAS epigenetic defects

T2 - Clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients

AU - Mantovani, Giovanna

AU - De Sanctis, Luisa

AU - Barbieri, Anna Maria

AU - Elli, Francesca M.

AU - Bollati, Valentina

AU - Vaira, Valentina

AU - Labarile, Pamela

AU - Bondioni, Sara

AU - Peverelli, Erika

AU - Lania, Andrea G.

AU - Beck-Peccoz, Paolo

AU - Spada, Anna

PY - 2010/2

Y1 - 2010/2

N2 - Context: The two main subtypes of pseudohypoparathyroidism (PHP), PHP-Ia and -Ib, are caused by mutations in GNAS exons 1-13 and methylation defects in the imprinted GNAS cluster, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO, and hormone resistance appears to be limited to PTH and TSH. Recently, methylation defects have been detected in few patients with PHP and mild AHO, indicating a molecular overlap between the two forms. Objectives: The aim of the study was to screen patients with clinically diagnosed PHP-Ia for methylation defects and to investigate the presence of correlations between the molecular findings and AHO severity. Patients and Methods: We investigated differential methylation of GNAS regions and STX16 microdeletions in genomic DNA from 40 patients with sporadic AHO and multihormone resistance, with no mutations in Gsα-coding GNAS exons. Results: Molecular analysis showed GNAS cluster imprinting defects in 24 of the 40 patients analyzed. No STX 16 deletion was detected. The presence of imprinting defects was not associated with the severity of AHO or with specific AHO signs. Conclusions: We report the largest series of the literature of patients with clinical AHO and multi-hormone resistance and no mutation in the Gsα gene. Our findings of frequent GNAS imprinting defects further confirm the existence of an overlap between molecular and clinical features of PHP-Ia and PHP-Ib and highlight the necessity of a new clinical classification of the disease that takes into account the recent knowledge on the molecular basis underlying these defects.

AB - Context: The two main subtypes of pseudohypoparathyroidism (PHP), PHP-Ia and -Ib, are caused by mutations in GNAS exons 1-13 and methylation defects in the imprinted GNAS cluster, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO, and hormone resistance appears to be limited to PTH and TSH. Recently, methylation defects have been detected in few patients with PHP and mild AHO, indicating a molecular overlap between the two forms. Objectives: The aim of the study was to screen patients with clinically diagnosed PHP-Ia for methylation defects and to investigate the presence of correlations between the molecular findings and AHO severity. Patients and Methods: We investigated differential methylation of GNAS regions and STX16 microdeletions in genomic DNA from 40 patients with sporadic AHO and multihormone resistance, with no mutations in Gsα-coding GNAS exons. Results: Molecular analysis showed GNAS cluster imprinting defects in 24 of the 40 patients analyzed. No STX 16 deletion was detected. The presence of imprinting defects was not associated with the severity of AHO or with specific AHO signs. Conclusions: We report the largest series of the literature of patients with clinical AHO and multi-hormone resistance and no mutation in the Gsα gene. Our findings of frequent GNAS imprinting defects further confirm the existence of an overlap between molecular and clinical features of PHP-Ia and PHP-Ib and highlight the necessity of a new clinical classification of the disease that takes into account the recent knowledge on the molecular basis underlying these defects.

UR - http://www.scopus.com/inward/record.url?scp=76149108406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149108406&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-0176

DO - 10.1210/jc.2009-0176

M3 - Article

C2 - 20061437

AN - SCOPUS:76149108406

VL - 95

SP - 651

EP - 658

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -